Robert Eugene Kristal - 14 Feb 2025 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role: Chief Financial Officer
Signature: /s/ Robert Kristal
Issuer symbol: BRTX
Transactions as of: 14 Feb 2025
Net transactions value: $0
Form type: 4
Filing time: 19 Feb 2025, 16:26:47 UTC
Previous filing: 15 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BRTX	Common Stock						7,994	14 Feb 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BRTX	Stock Option	Award	$0	+166,492		$0.000000	166,492	14 Feb 2025	Common Stock	166,492	$2.46	Direct	F4
holding	BRTX	Stock Option						10,490	14 Feb 2025	Common Stock	10,490	$5.08	Direct	F1
holding	BRTX	Stock Option						88,968	14 Feb 2025	Common Stock	88,968	$2.91	Direct	F2
holding	BRTX	Stock Option						263,158	14 Feb 2025	Common Stock	263,158	$1.45	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option is currently exercisable.
F2	The option vests and becomes exercisable to the extent of 44,484 shares on February 17, 2023 with the remaining 44,484 shares vesting in eight nearly-equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested.
F3	The option vests and becomes exercisable to the extent of 131,579 shares on February 13, 2024 with the remaining 131,579 shares vesting in eight nearly-equal quarterly installments beginning on February 13, 2025 and continuing every three months thereafter until fully vested.
F4	The option vests and becomes exercisable to the extent of 83,246 shares on February 14, 2025 with the remaining 83,246 shares vesting in eight nearly-equal quarterly installments beginning on February 14, 2026 and continuing every three months thereafter until fully vested.